Winship Cancer Institute of Emory University

Latest from Winship Cancer Institute of Emory University
Patritumab Deruxtecan Produces Early Responses in Advanced NSCLC Regardless of Variant Genomic Alterations
June 17, 2022
Article
Regardless of other identified driver genomic alterations, patients with heavily pretreated, advanced, non–small cell lung cancer achieved encouraging responses with patritumab deruxtecan.
Checkpoint Inhibitors Present Unique Adverse Events, Require Careful Management Strategies in Breast Cancer
March 20, 2022
Article
La-Urshala Brock, FNP-BC, CNM, RNFA, discusses effective toxicity management for patients with breast cancer receiving pembrolizumab.
Radiotherapy Treatments Continue With Patient-Friendly Focus in Prostate Cancer
March 18, 2022
Article
Radiotherapy treatment has continued to evolve to become both shorter and faster in potentially curing prostate cancer.
New Research Seeks to Incorporate Immunotherapy into Early Lines of ESCC Treatment
March 11, 2022
Article
Investigators are looking to evaluate whether immunotherapy in the frontline setting, with or without chemotherapy, might improve prognoses for advanced esophageal squamous cell carcinoma.
Winship Cancer Institute’s Take on Caring For Patients with Cancer Over The Holidays
December 23, 2021
Article
Christopher Zorn, clinic operations administrator of Winship Cancer Institute at Emory University, discusses how Winship Cancer Institute fosters a safe, yet festive, holiday environment during the COVID-19 pandemic.
Merry and Bright: Bringing a Festive Air into the Oncology Space for the Holidays
December 01, 2021
Podcast
In this episode of “The Vitals,” 2 health care professionals discuss how to safely celebrate the holidays in oncology units.